BRPI0714724A2 - Métodos para tratar enterite, para proteger contra a enterite, contra a lesão à mucosa de cólon e contra a inflamação colorretal induzidas pela radiação, para tratar enterite em um indivíduo ou monitorar o progresso de um indivíduo que é tratado de enterite, para selecionar um indivíduo para o tratamento de enterite, e, para tratar diarréia profilaticamente. - Google Patents

Métodos para tratar enterite, para proteger contra a enterite, contra a lesão à mucosa de cólon e contra a inflamação colorretal induzidas pela radiação, para tratar enterite em um indivíduo ou monitorar o progresso de um indivíduo que é tratado de enterite, para selecionar um indivíduo para o tratamento de enterite, e, para tratar diarréia profilaticamente.

Info

Publication number
BRPI0714724A2
BRPI0714724A2 BRPI0714724-4A BRPI0714724A BRPI0714724A2 BR PI0714724 A2 BRPI0714724 A2 BR PI0714724A2 BR PI0714724 A BRPI0714724 A BR PI0714724A BR PI0714724 A2 BRPI0714724 A2 BR PI0714724A2
Authority
BR
Brazil
Prior art keywords
enteritis
individual
treat
prophylactically
progress
Prior art date
Application number
BRPI0714724-4A
Other languages
English (en)
Inventor
Doug Bettenhausen
Christopher Jahraus
Original Assignee
Salix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salix Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Inc
Publication of BRPI0714724A2 publication Critical patent/BRPI0714724A2/pt
Publication of BRPI0714724A8 publication Critical patent/BRPI0714724A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0714724A 2006-08-02 2007-08-02 métodos para tratar enterite, para proteger contra a enterite, contra a lesão à mucosa do cólon e contra a inflamação colorretal induzidas pela radiação, para tratar enterite em um indivíduo ou monitorar o progresso de um indivíduo que é tratado de enterite, para selecionar um indivíduo para o tratamento de enterite, e, para tratar diarréia profilaticamente. BRPI0714724A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83527306P 2006-08-02 2006-08-02
US85029906P 2006-10-06 2006-10-06
PCT/US2007/017379 WO2008016708A2 (en) 2006-08-02 2007-08-02 Methods for treatment of radiation enteritis

Publications (2)

Publication Number Publication Date
BRPI0714724A2 true BRPI0714724A2 (pt) 2015-07-07
BRPI0714724A8 BRPI0714724A8 (pt) 2018-04-10

Family

ID=38997731

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0714724A BRPI0714724A8 (pt) 2006-08-02 2007-08-02 métodos para tratar enterite, para proteger contra a enterite, contra a lesão à mucosa do cólon e contra a inflamação colorretal induzidas pela radiação, para tratar enterite em um indivíduo ou monitorar o progresso de um indivíduo que é tratado de enterite, para selecionar um indivíduo para o tratamento de enterite, e, para tratar diarréia profilaticamente.

Country Status (17)

Country Link
EP (1) EP2054066B1 (pt)
JP (3) JP5844961B2 (pt)
KR (2) KR20150132214A (pt)
CN (1) CN104382900A (pt)
AU (1) AU2007281413B2 (pt)
BR (1) BRPI0714724A8 (pt)
CA (1) CA2659874C (pt)
DK (1) DK2054066T3 (pt)
ES (1) ES2538478T3 (pt)
HK (1) HK1130199A1 (pt)
HU (1) HUE025306T2 (pt)
IL (1) IL196843A (pt)
MX (1) MX2009001342A (pt)
PL (1) PL2054066T3 (pt)
PT (1) PT2054066E (pt)
SI (1) SI2054066T1 (pt)
WO (1) WO2008016708A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
AU2007281413B2 (en) * 2006-08-02 2013-10-31 Christopher Jahraus Compositions and methods for the treatment of radiation proctosigmoiditis
DK2327407T3 (da) 2008-09-26 2014-08-25 Aska Pharm Co Ltd Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme
US20110035232A1 (en) 2008-10-02 2011-02-10 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
PL2350096T3 (pl) 2008-10-02 2020-06-29 Salix Pharmaceuticals, Ltd. Sposoby leczenia encefalopatii wątrobowej
KR101906177B1 (ko) * 2008-12-10 2018-10-10 시플라 리미티드 리팍시민 복합체
BRPI1008058A8 (pt) * 2009-02-11 2018-03-27 Cedars Sinai Medical Center uso de antibióticos para reduzir a probabilidade de desenvolver síndrome do intestino irritável pós-infecciosa
US9110081B2 (en) 2009-02-11 2015-08-18 Cedars-Sinai Medical Center Antibody to cytolethal distending toxin of Campylobacter jejuni
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
MX2015003326A (es) 2012-09-17 2015-08-12 Cedars Sinai Medical Center Diagnostico y tratamiento de trastornos de la motilidad de los intestinos y la vejiga, y de la fibromialgia.
MX2016016458A (es) * 2014-06-30 2017-07-13 Salix Pharmaceuticals Inc Métodos para repetir tratamiento de síndrome del intestino irritable (ibs).
CN105477624A (zh) * 2015-12-16 2016-04-13 官键 一种用于治疗放射性直肠炎的药物组合物
RU2618452C1 (ru) * 2015-12-28 2017-05-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) Способ прогнозирования энтерита

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1199374B (it) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1290679B1 (it) * 1997-02-14 1998-12-10 Alfa Wassermann Spa Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
ITMI20032144A1 (it) 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
AU2007281413B2 (en) * 2006-08-02 2013-10-31 Christopher Jahraus Compositions and methods for the treatment of radiation proctosigmoiditis

Also Published As

Publication number Publication date
JP2013227350A (ja) 2013-11-07
HK1130199A1 (en) 2009-12-24
CN104382900A (zh) 2015-03-04
BRPI0714724A8 (pt) 2018-04-10
IL196843A0 (en) 2009-11-18
WO2008016708A2 (en) 2008-02-07
HUE025306T2 (hu) 2016-01-28
JP2016028079A (ja) 2016-02-25
CA2659874C (en) 2016-10-11
WO2008016708A3 (en) 2008-06-19
DK2054066T3 (en) 2015-06-08
EP2054066A2 (en) 2009-05-06
JP5844961B2 (ja) 2016-01-20
AU2007281413A1 (en) 2008-02-07
ES2538478T3 (es) 2015-06-22
EP2054066B1 (en) 2015-04-15
IL196843A (en) 2016-03-31
JP2009545602A (ja) 2009-12-24
EP2054066A4 (en) 2011-01-05
CA2659874A1 (en) 2008-02-07
AU2007281413B2 (en) 2013-10-31
SI2054066T1 (sl) 2015-08-31
PL2054066T3 (pl) 2015-12-31
MX2009001342A (es) 2009-08-31
JP5993074B2 (ja) 2016-09-14
KR20090047490A (ko) 2009-05-12
KR20150132214A (ko) 2015-11-25
PT2054066E (pt) 2015-07-16

Similar Documents

Publication Publication Date Title
BRPI0714724A2 (pt) Métodos para tratar enterite, para proteger contra a enterite, contra a lesão à mucosa de cólon e contra a inflamação colorretal induzidas pela radiação, para tratar enterite em um indivíduo ou monitorar o progresso de um indivíduo que é tratado de enterite, para selecionar um indivíduo para o tratamento de enterite, e, para tratar diarréia profilaticamente.
EP2020948A4 (en) TREATMENT DEVICE AND METHOD FOR TREATING OR PREVENTING PERIODONTOPATHY THROUGH HEAT APPLICATION
IL269370B (en) Chemicals, preparations and methods for the treatment and prevention of orthopoxvirus infections and related diseases
WO2007095618A3 (en) Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
IL195201A (en) Composition for use in the treatment of a disease or condition caused or associated with hyperactive cholinergic nerve of the patient or exocrine glands in the patient and a method of reducing facial lines or wrinkles or removing asymmetry of the face
ZA200709045B (en) Treatment device and method for treating skin lesions through application of heat
WO2010065662A3 (en) Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
BRPI0815283A2 (pt) Equipamento para o tratamento da biomassa, método para o tratamento da biomassa, biomassa tratada e hidrolisado
WO2008027357A3 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
WO2010036395A3 (en) Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
NO20083240L (no) Sammensetninger og fremgangsmater for forebygging og behandling av kakeksia
WO2010102058A3 (en) Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1
WO2006102439A3 (en) Treatment or prevention of cancer and precancerous disorders
WO2009129147A3 (en) Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
BRPI0910686A2 (pt) células perivasculares do cordão umbilical humano geneticamente modificadas para a profilaxia contra agentes biológicos e químicos ou para o tratamento dos mesmos.
BRPI1011372A2 (pt) método e montagem para tratar um material plano a ser tratado e dispositivo para remover ou reter líquido de tratamento
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
AR062658A1 (es) Terapias de combinacion para artritis reumatoide
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
WO2008016640A3 (en) Use of poloxamer for the prevention and/or treatment of heart failure
WO2008155390A3 (en) Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases.
BRPI0819158A2 (pt) Método para proteção de uma planta contra um fitopatógeno, uso de um composto, e, agente para tratar as sementes de uma planta
PL3156057T3 (pl) Powlekany delmopinolem gryzak dla zwierząt do stosowania w zapobieganiu lub leczeniu halitozy
NO20073104L (no) Anvendelse av en 5-HT6 agonist for behandling og forebygging av neurodegenerative forstyrrelser

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements